Homeβ€ΊSearchβ€ΊCritical Reviews in Therapeutic Drug Carrier Systems

Critical Reviews in Therapeutic Drug Carrier Systems

Begell House Inc. Β· United States

ISSN0743-4863eISSN2162-660X
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.469
H-Indexi
87
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.562
Total Worksi
615
Total Citationsi
27,980
2yr Mean Citednessi
1.58
Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Critical Reviews in Therapeutic Drug Carrier Systems publishes work on therapeutic drug carrier systems. Recent advances include long-acting drug delivery technologies for pain medicine and lipid-based nanovesicular delivery systems for melanoma therapy. The journal also covers the use of nonionic block copolymers in vaccines and therapeutics.

AI-compiled from public web sources Β· verify on publisher page β†’

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Publishedβ€”
FrequencySix No. A Year, 1998-
StatusActive
Total Publications615
Publisher OrgBegell House
Visit Journal Website

Submission Info

Publishing ModelSubscription
Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Begell House Inc.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
0743-4863 / 2162-660X
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
10
120
2019
28
307
2020
29
331
2021
29
233
2022
25
110
2023
17
61
2024
27
36
2025
9
0
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Pharmaceutical ScienceQ2
Medicine (miscellaneous)Q3
PharmacologyQ3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyPharmaceutical ScienceMedicine (miscellaneous)

Research Topics (OpenAlex)

Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery SystemsRNA Interference and Gene DeliveryAdvancements in Transdermal Drug DeliveryAdvanced biosensing and bioanalysis techniquesLipid Membrane Structure and BehaviorInhalation and Respiratory Drug DeliveryInnovative Microfluidic and Catalytic Techniques InnovationComputational Drug Discovery Methods

Frequently asked questions about Critical Reviews in Therapeutic Drug Carrier Systems

Is Critical Reviews in Therapeutic Drug Carrier Systems a predatory journal?

PubScope has no integrity flags on record for Critical Reviews in Therapeutic Drug Carrier Systems: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Critical Reviews in Therapeutic Drug Carrier Systems?

Critical Reviews in Therapeutic Drug Carrier Systems is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.58.

Is Critical Reviews in Therapeutic Drug Carrier Systems indexed in Scopus and Web of Science?

Critical Reviews in Therapeutic Drug Carrier Systems is indexed in Web of Science, Scopus.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref